Effects of Ginseng Consumption on Cardiovascular Health Biomarkers in Adults: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials

Fuente: Wiley Open Access
Guardado en:
Detalles Bibliográficos
Autores principales: Xiao‐Feng Zhang, Rui‐Xue Min, Zhen Wang, Yue Qi, Ruo‐Nan Li, Jian‐Ming Fan
Formato: Artículo Open Access
Publicado: Wiley 2024
Materias:
Acceso en línea:
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
_version_ 1867021788160983040
author Xiao‐Feng Zhang
Rui‐Xue Min
Zhen Wang
Yue Qi
Ruo‐Nan Li
Jian‐Ming Fan
author_facet Xiao‐Feng Zhang
Rui‐Xue Min
Zhen Wang
Yue Qi
Ruo‐Nan Li
Jian‐Ming Fan
Xiao‐Feng Zhang
Rui‐Xue Min
Zhen Wang
Yue Qi
Ruo‐Nan Li
Jian‐Ming Fan
collection Wiley Open Access
contents Effects of Ginseng Consumption on Cardiovascular Health Biomarkers in Adults: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials Xiao‐Feng Zhang Rui‐Xue Min Zhen Wang Yue Qi Ruo‐Nan Li Jian‐Ming Fan Phytotherapy Research ABSTRACTGinseng, with various pharmacological activities, has received increasing attention to improve cardiovascular health (CVH). Therefore, this meta‐analysis synthesized the effect of ginseng consumption on biomarkers of CVH in adults. A systematic search was performed in the databases of PubMed, Scopus, Web of Science, Embase, and the Cochrane Library through July 24, 2023 to screen out English‐language randomized controlled trials (RCTs) evaluating the effects of ginseng consumption on body composition, blood pressure, vascular stiffness, lipid metabolism, glucose metabolism, insulin resistance, inflammatory cytokines, and adipocytokines in adults. The weighted mean difference (WMD) and 95% confidence interval (CI) were used to evaluate the overall effect size, and STATA 12.0 was used for comprehensive analysis. Forty‐five studies were included in the meta‐analysis. Ginseng consumption significantly reduced systolic blood pressure (SBP) (WMD = −2.57 mmHg, 95% CI = −4.99 to −0.14, p = 0.038), total cholesterol (TC) (WMD = −4.40 mg/dL, 95% CI = −8.67 to −0.132, p = 0.043), low density lipoprotein cholesterol (LDL‐C) (WMD = −2.81 mg/dL, 95% CI = −4.89 to −0.72, p = 0.008), C‐reactive protein (CRP) (WMD = −0.41 mg/L, 95% CI = −0.73 to −0.10, p = 0.010), and interleukin‐6 (IL‐6) (WMD = −2.82 pg./mL, 95% CI = −4.31 to −1.32, p < 0.001). Subgroup analyses suggested that supplementation with ginseng for less than 12 weeks significantly reduced SBP, but 12 weeks or more improved TC and CRP. Ginseng consumption on SBP, TC, and CRP seemed to be more effective on unhealthy participants. The meta‐analysis showed that ginseng consumption might have the potential to improve SBP, TC, LDL‐C, CRP, and IL‐6. These findings suggest that ginseng is a potential candidate for the maintenance of CVH. However, our results had high heterogeneity. Future high‐quality studies are needed to firmly establish the clinical efficacy of ginseng consumption. 10.1002/ptr.8339 http://onlinelibrary.wiley.com/termsAndConditions#vor
doi_str_mv 10.1002/ptr.8339
format Artículo Open Access
id wiley_oa_10_1002_ptr_8339
institution Wiley Open Access
license_str_mv http://onlinelibrary.wiley.com/termsAndConditions#vor
publishDate 2024
publisher Wiley
record_format wiley_oa
spellingShingle Effects of Ginseng Consumption on Cardiovascular Health Biomarkers in Adults: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
Xiao‐Feng Zhang
Rui‐Xue Min
Zhen Wang
Yue Qi
Ruo‐Nan Li
Jian‐Ming Fan
Phytotherapy Research
Effects of Ginseng Consumption on Cardiovascular Health Biomarkers in Adults: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials Xiao‐Feng Zhang Rui‐Xue Min Zhen Wang Yue Qi Ruo‐Nan Li Jian‐Ming Fan Phytotherapy Research ABSTRACTGinseng, with various pharmacological activities, has received increasing attention to improve cardiovascular health (CVH). Therefore, this meta‐analysis synthesized the effect of ginseng consumption on biomarkers of CVH in adults. A systematic search was performed in the databases of PubMed, Scopus, Web of Science, Embase, and the Cochrane Library through July 24, 2023 to screen out English‐language randomized controlled trials (RCTs) evaluating the effects of ginseng consumption on body composition, blood pressure, vascular stiffness, lipid metabolism, glucose metabolism, insulin resistance, inflammatory cytokines, and adipocytokines in adults. The weighted mean difference (WMD) and 95% confidence interval (CI) were used to evaluate the overall effect size, and STATA 12.0 was used for comprehensive analysis. Forty‐five studies were included in the meta‐analysis. Ginseng consumption significantly reduced systolic blood pressure (SBP) (WMD = −2.57 mmHg, 95% CI = −4.99 to −0.14, p = 0.038), total cholesterol (TC) (WMD = −4.40 mg/dL, 95% CI = −8.67 to −0.132, p = 0.043), low density lipoprotein cholesterol (LDL‐C) (WMD = −2.81 mg/dL, 95% CI = −4.89 to −0.72, p = 0.008), C‐reactive protein (CRP) (WMD = −0.41 mg/L, 95% CI = −0.73 to −0.10, p = 0.010), and interleukin‐6 (IL‐6) (WMD = −2.82 pg./mL, 95% CI = −4.31 to −1.32, p < 0.001). Subgroup analyses suggested that supplementation with ginseng for less than 12 weeks significantly reduced SBP, but 12 weeks or more improved TC and CRP. Ginseng consumption on SBP, TC, and CRP seemed to be more effective on unhealthy participants. The meta‐analysis showed that ginseng consumption might have the potential to improve SBP, TC, LDL‐C, CRP, and IL‐6. These findings suggest that ginseng is a potential candidate for the maintenance of CVH. However, our results had high heterogeneity. Future high‐quality studies are needed to firmly establish the clinical efficacy of ginseng consumption. 10.1002/ptr.8339 http://onlinelibrary.wiley.com/termsAndConditions#vor
title Effects of Ginseng Consumption on Cardiovascular Health Biomarkers in Adults: A Systematic Review and Meta‐Analysis of Randomized Controlled Trials
topic Phytotherapy Research
url https://onlinelibrary.wiley.com/doi/10.1002/ptr.8339